Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031540 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Indiana Zorkau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia. Hauptthemen laut MEDLINE: Interleukin-1, Inflammatory Bowel Diseases, Receptors, Interleukin-1, T-Lymphocyte Subsets. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gastroenterological Society of Australia, Royal Australasian College of Physicians, National Health and Medical Research Council.
Abstract (Originalsprache)
IBD pathogenesis is underpinned by an imbalance between excess inflammation caused by effector T-cells and inadequate suppression by regulatory T-cells (Tregs). Interleukin-37 (IL-37) is a potent, anti-inflammatory cytokine that signals via its receptors IL-1R5 and IL-1R8. Hence, augmenting anti-inflammatory mechanisms that drive IL-37 expression is a strategy to control IBD-associated inflammation. However, the role of IL-37 and its receptors in T-cells remains incompletely understood. Here, we investigated T-cell expression profiles of IL-37 and its receptors to understand the drivers of dysregulated T-cell responses in IBD and develop novel, more effective therapies. T-cell subsets from healthy control (HC), Crohn’s disease (CD) and ulcerative colitis (UC) peripheral blood mononuclear cells (PBMC) and lamina propria mononuclear cells (LPMC) were assessed for expression of IL-37 and its receptors by flow cytometry. CD3+IL-1R8+ T-cell transcriptomes underwent RNA sequencing. The phenotype and suppressive capacity of Tregs supplemented with IL-37 was assessed in vitro. Our results indicate that IL-37 and its receptors were differentially expressed among PBMC and LPMC T-cell subsets in IBD patients compared to HC. Transcription signatures unique to IBD were revealed, particularly histone and mitochondrial pathways. Remarkably, culturing Tregs with IL-37 preserved FOXP3 expression and suppressiveness at a level comparable to treatment with the well-established Treg stabilizing agent rapamycin. Altogether, our study identified differences in T-cells expressing IL-37 and its receptors that are indicative of T-cell dysfunction in IBD. These findings highlight a novel and promising avenue for restoring immune homeostasis in IBD by targeting and boosting the IL-37 signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
- The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia.
- Department of Paediatrics, Monash University, Clayton, VIC 3168, Australia.
- Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
- School of Biomedical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
- Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
ORCID-Profile: Peter J Eggenhuizen, Marie Lee, Steven X Cho, Kylie R James, Andrew M Ellisdon, James C Whisstock, Joshua D Ooi, Marcel F Nold, Claudia A Nold-Petry, Rimma Goldberg
Förderung
- Gastroenterological Society of Australia
- Royal Australasian College of Physicians
- National Health and Medical Research Council
- Fielding Foundation
- Ramaciotti Health Investment Grant
- Victorian Cancer Agency Fellowship
- the Gastroenterological Society of Australia
- the Royal Australasian College of Physicians
Zitieren
APA
Zorkau, I., Eggenhuizen, P. J., Lee, M., Cho, S. X., James, K. R., Ellisdon, A. M., Whisstock, J. C., Ooi, J. D., Nold, M. F., Nold-Petry, C. A., & Goldberg, R. (2026). Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031540
Vancouver
Zorkau I, Eggenhuizen PJ, Lee M, Cho SX, James KR, Ellisdon AM, et al. Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031540
BibTeX
@article{Zorkau2026,
author = {Zorkau, Indiana and Eggenhuizen, Peter J and Lee, Marie and Cho, Steven X and James, Kylie R and Ellisdon, Andrew M and Whisstock, James C and Ooi, Joshua D and Nold, Marcel F and Nold-Petry, Claudia A and Goldberg, Rimma},
title = {Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031540}
}
EUVIMED